Chronic Pain: Low-dose naltrexone (LDN) has been demonstrated to reduce symptom severity in conditions such as fibromyalgia, Crohns disease, multiple sclerosis, and complex regional pain syndrome
Effect of flavin compounds on glutathione reductase activity: in vivo and in vitro studies
GLP-1 medications including semaglutide and tirzepatide have helped millions lose weight, yet some users report depressive symptoms during treatment
Commonly used supplements include omega-3 fatty acids (like fish oil), vitamin D, magnesium combined with vitamin B6, probiotics, and herbal compounds
The accelerated protocol works best for individuals who have already demonstrated tolerance to GLP-1 medications through previous semaglutide or tirzepatide use
Rather than overriding pain signals, this model works to identify and address the root causes of chronic pain such as chronic inflammation, tissue injury, biomechanical imbalance, nutrient depletion, metabolic dysfunction, gut-immune disruption, or nervous system sensitization
